3dux Citations

Think twice: understanding the high potency of bis(phenyl)methane inhibitors of thrombin.

J Mol Biol 391 552-64 (2009)
Related entries: 2zc9, 2zda, 2zfp, 2zgx, 2zo3, 3dhk, 3f68

Cited: 21 times
EuropePMC logo PMID: 19520086

Abstract

Successful design of potent and selective protein inhibitors, in terms of structure-based drug design, strongly relies on the correct understanding of the molecular features determining the ligand binding to the target protein. We present a case study of serine protease inhibitors with a bis(phenyl)methane moiety binding into the S3 pocket. These inhibitors bind with remarkable potency to the active site of thrombin, the blood coagulation factor IIa. A combination of X-ray crystallography and isothermal titration calorimetry provides conclusive insights into the driving forces responsible for the surprisingly high potency of these inhibitors. Analysis of six well-resolved crystal structures (resolution 1.58-2.25 A) along with the thermodynamic data allows an explanation of the tight binding of the bis(phenyl)methane inhibitors. Interestingly, the two phenyl rings contribute to binding affinity for very different reasons - a fact that can only be elucidated by a structure-based approach. The first phenyl moiety occupies the hydrophobic S3 pocket, resulting in a mainly entropic advantage of binding. This observation is based on the displacement of structural water molecules from the S3 pocket that are observed in complexes with inhibitors that do not bind in the S3 pocket. The same classic hydrophobic effect cannot explain the enhanced binding affinity resulting from the attachment of the second, more solvent-exposed phenyl ring. For the bis(phenyl)methane inhibitors, an observed adaptive rotation of a glutamate residue adjacent to the S3 binding pocket attracted our attention. The rotation of this glutamate into salt-bridging distance with a lysine moiety correlates with an enhanced enthalpic contribution to binding for these highly potent thrombin binders. This explanation for the magnitude of the attractive force is confirmed by data retrieved by a Relibase search of several thrombin-inhibitor complexes deposited in the Protein Data Bank exhibiting similar molecular features. Special attention was attributed to putative changes in the protonation states of the interaction partners. For this purpose, two analogous inhibitors differing mainly in their potential to change the protonation state of a hydrogen-bond donor functionality were compared. Buffer dependencies of the binding enthalpy associated with complex formation could be traced by isothermal titration calorimetry, which revealed, along with analysis of the crystal structures (resolution 1.60 and 1.75 A), that a virtually compensating proton interchange between enzyme, inhibitor and buffer is responsible for the observed buffer-independent thermodynamic signatures.

Articles - 3dux mentioned but not cited (4)

  1. Structure-based predictions of activity cliffs. Husby J, Bottegoni G, Kufareva I, Abagyan R, Cavalli A. J Chem Inf Model 55 1062-1076 (2015)
  2. Platelet aggregation pathway network-based approach for evaluating compounds efficacy. Gu J, Li Q, Chen L, Li Y, Hou T, Yuan G, Xu X. Evid Based Complement Alternat Med 2013 425707 (2013)
  3. Stacking with No Planarity? Gunaydin H, Bartberger MD. ACS Med Chem Lett 7 341-344 (2016)
  4. How Good is Jarzynski's Equality for Computer-Aided Drug Design? Ho K, Truong DT, Li MS. J Phys Chem B 124 5338-5349 (2020)


Reviews citing this publication (3)

Articles citing this publication (14)

  1. Water in cavity-ligand recognition. Baron R, Setny P, McCammon JA. J Am Chem Soc 132 12091-12097 (2010)
  2. A systematic analysis of atomic protein-ligand interactions in the PDB. Ferreira de Freitas R, Schapira M. Medchemcomm 8 1970-1981 (2017)
  3. Reproducing crystal binding modes of ligand functional groups using Site-Identification by Ligand Competitive Saturation (SILCS) simulations. Raman EP, Yu W, Yu W, Guvench O, Mackerell AD. J Chem Inf Model 51 877-896 (2011)
  4. Rapid decomposition and visualisation of protein-ligand binding free energies by residue and by water. Woods CJ, Malaisree M, Michel J, Long B, McIntosh-Smith S, Mulholland AJ. Faraday Discuss 169 477-499 (2014)
  5. Site Identification by Ligand Competitive Saturation (SILCS) simulations for fragment-based drug design. Faller CE, Raman EP, MacKerell AD, Guvench O. Methods Mol Biol 1289 75-87 (2015)
  6. Impact of ligand and protein desolvation on ligand binding to the S1 pocket of thrombin. Biela A, Khayat M, Tan H, Kong J, Heine A, Hangauer D, Klebe G. J Mol Biol 418 350-366 (2012)
  7. Improved Modeling of Halogenated Ligand-Protein Interactions Using the Drude Polarizable and CHARMM Additive Empirical Force Fields. Lin FY, MacKerell AD. J Chem Inf Model 59 215-228 (2019)
  8. Marine Diterpenes: Molecular Modeling of Thrombin Inhibitors with Potential Biotechnological Application as an Antithrombotic. Pereira RC, Lourenço AL, Terra L, Abreu PA, Laneuville Teixeira V, Castro HC. Mar Drugs 15 E79 (2017)
  9. Experimental and computational active site mapping as a starting point to fragment-based lead discovery. Behnen J, Köster H, Neudert G, Craan T, Heine A, Klebe G. ChemMedChem 7 248-261 (2012)
  10. Attacking COVID-19 Progression Using Multi-Drug Therapy for Synergetic Target Engagement. Coban MA, Morrison J, Maharjan S, Hernandez Medina DH, Li W, Zhang YS, Freeman WD, Radisky ES, Le Roch KG, Weisend CM, Ebihara H, Caulfield TR. Biomolecules 11 787 (2021)
  11. Directed C(sp3)-H arylation of tryptophan: transformation of the directing group into an activated amide. Nicke L, Horx P, Harms K, Geyer A. Chem Sci 10 8634-8641 (2019)
  12. Boosting Affinity by Correct Ligand Preorganization for the S2 Pocket of Thrombin: A Study by Isothermal Titration Calorimetry, Molecular Dynamics, and High-Resolution Crystal Structures. Rühmann EH, Rupp M, Betz M, Heine A, Klebe G. ChemMedChem 11 309-319 (2016)
  13. Beyond heparinization: design of highly potent thrombin inhibitors suitable for surface coupling. Steinmetzer T, Baum B, Biela A, Klebe G, Nowak G, Bucha E. ChemMedChem 7 1965-1973 (2012)
  14. Mn-Catalyzed 1,6-conjugate addition/aromatization of para-quinone methides. Yang B, Yao W, Xia XF, Wang D. Org Biomol Chem 16 4547-4557 (2018)